News summaryStablecoin Development / NYSE American statement, reported by TipRanksNov 16, 2026, 12:00 PM
Lucid Capital raised its HELP target to $79 from $52 and retained Buy
On Nov. 16, 2026, Lucid Capital raised its price target to $79 from $52, kept Buy, and increased its HLP003 probability-of-success estimate to 70% from 45% after APPROACH results. The firm attributed the day’s share-price selloff to investor misunderstanding of the treatment modality and indication.